← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2009Last known activity
Dec 6, 2024
Timeline
1940s
- Jan 1, 1949
George Mason University— Founded
Drugs by trial phase (17 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06856525CollaboratorPhase 2/Phase 3Dec 6, 2024
- NCT04723134CollaboratorPhase 2Mar 1, 2021
- NCT03894137CollaboratorN/AOct 31, 2019
- NCT03376659CollaboratorPhase 1/Phase 2Aug 8, 2018
- NCT03651089CollaboratorPhase 1Jul 16, 2018
- NCT03859583Lead sponsorN/AMay 29, 2018
- NCT03859583Reponsible party - principal investigatorN/AMay 29, 2018
- NCT03269617CollaboratorN/AOct 1, 2016
- NCT02433873Reponsible party - principal investigatorN/AApr 1, 2015
- NCT02433873Overall official - principal investigatorN/AApr 1, 2015
- NCT02433873Lead sponsorN/AApr 1, 2015
- NCT03583138CollaboratorPhase 4Jun 23, 2014
- NCT03583138Overall official - principal investigatorPhase 4Jun 23, 2014
- NCT01550341Overall official - principal investigatorN/AApr 1, 2012
- NCT01550341CollaboratorN/AApr 1, 2012
Details
- Founded
- Fairfax, VA, US Jan 1, 1949
- Last known activity
- Dec 6, 2024